PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22369693 ↗2012Reported benefit

Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice.

MouseSpinal cord injuryUnspecifiedJcl:ICRMalen = 211 mice total; MR16-1 n=85, rat IgG n=85, saline n=25, sha…Intraperitoneal50 microgram per gram body weightImmediately after injury

Model: Thoracic spinal cord injury after laminectomy

MR16-1 increased spared myelin, axonal markers and Basso Mouse Scale scores (5.0 +/- 0.3 versus 2.8 +/- 0.3), lowered Th1 cytokines and promoted M2 macrophages.

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.